Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care ConferenceBusiness Wire • 02/23/26
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-ThalassemiaBusiness Wire • 02/23/26
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?Zacks Investment Research • 02/20/26
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple MyelomaBusiness Wire • 02/17/26
BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?Zacks Investment Research • 02/09/26
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial IntelligenceBusiness Wire • 02/09/26
Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat EstimatesZacks Investment Research • 02/05/26